Structures by: Yalçın Ş. P.
Total: 15
<i>N</i>-(3-Oxo-1-thia-4-azaspiro[4.5]dec-4-yl)-6- phenylimidazo[2,1-<i>b</i>][1,3]thiazole-3-acetamide hemihydrate
C21H22N4O2S2,0.5(H2O)
Acta Crystallographica Section E (2008) 64, 5 o810-o811
a=11.0175(3)Å b=11.8817(3)Å c=17.6162(5)Å
α=75.123(2)° β=73.502(2)° γ=81.012(2)°
<i>N</i>-(2,6-Dimethyl-3-oxo-1-thia-4-azaspiro[4.5]dec-4-yl)-2-hydroxy-2,2- diphenylacetamide
C24H28N2O3S
Acta Crystallographica Section E (2008) 64, 10 o1919
a=9.4942(4)Å b=20.6765(5)Å c=12.0052(4)Å
α=90° β=105.063(2)° γ=90°
8-Ethyl-2-hydroxy-2-methyl-4-morpholinoethyl-1-thia- 4-azaspiro[4.5]decan-3-one
C17H30N2O3S
Acta Crystallographica Section E (2008) 64, 10 o1939-o1940
a=8.1878(4)Å b=10.2241(5)Å c=12.2188(6)Å
α=79.901(4)° β=73.796(4)° γ=67.674(4)°
<i>rac</i>-2-Hydroxy-2,8-dimethyl-4-morpholinoethyl-1-thia-4- azaspiro[4.5]decan-3-one
C16H28N2O3S
Acta Crystallographica Section E (2008) 64, 8 o1574-o1575
a=8.0753(4)Å b=10.2002(5)Å c=11.8734(6)Å
α=82.467(4)° β=71.487(4)° γ=68.965(4)°
8-Methyl-4-morpholinoethyl-1-thia-4-azaspiro[4.5]decan-3-one
C15H26N2O2S
Acta Crystallographica Section E (2008) 64, 8 o1572-o1573
a=7.8629(4)Å b=10.5239(6)Å c=10.8252(6)Å
α=94.974(5)° β=106.378(5)° γ=107.169(4)°
Di-μ-iodido- bis{[(4-fluorobenzoylmethylene)triphenyl-λ^5^-phosphorane]iodidomercury(II)}
C52H40F2Hg2I4O2P2
Acta Crystallographica Section E (2008) 64, 5 m612-m613
a=10.0346(16)Å b=11.8594(19)Å c=13.235(2)Å
α=92.513(13)° β=111.293(12)° γ=113.117(12)°
1,3-Bis(3-phenylpropyl)1H-benzimidazole-2(3H)-tellurone
C25H26N2Te
Acta Crystallographica Section E (2008) 64, 3 o621-o622
a=10.6004(2)Å b=10.6004(2)Å c=20.4365(6)Å
α=90° β=90° γ=90°
Diethyl 5-[(2-hydroxy-1-naphthyl)methylideneamino]-3-methylthiophene-2,4-dicarboxylate
C22H21NO5S
Acta Crystallographica Section E (2008) 64, 5 o923
a=8.7111(4)Å b=11.5319(5)Å c=11.9778(5)Å
α=61.594(3)° β=79.489(3)° γ=89.334(3)°
3-Chloro-<i>N</i>-(4-sulfamoylphenyl)propanamide
C9H11ClN2O3S
Acta Crystallographica Section E (2010) 66, 7 o1559-o1560
a=7.7554(4)Å b=14.8191(8)Å c=9.7482(5)Å
α=90° β=94.181(4)° γ=90°
C36H25NO3
C36H25NO3
Acta Crystallographica Section E (2009) 65, 3 o626-o627
a=11.8496(3)Å b=15.3168(5)Å c=14.9883(4)Å
α=90° β=106.536(2)° γ=90°
Dichloridobis[5-nitro-1-trimethylsilylmethyl-1<i>H</i>-benzimidazole- κ<i>N</i>^3^]cobalt(II) <i>N</i>,<i>N</i>-dimethylformamide solvate
C22H30Cl2CoN6O4Si2,C3H7NO
Acta Crystallographica Section E (2010) 66, 3 m253-m254
a=9.8982(4)Å b=11.6936(5)Å c=15.9293(6)Å
α=106.041(2)° β=107.408(2)° γ=99.040(3)°
2-Chloro-<i>N</i>-(4-sulfamoylphenyl)acetamide
C8H9ClN2O3S
Acta Crystallographica Section E (2010) 66, 7 o1596
a=4.7870(2)Å b=14.1868(9)Å c=16.0158(9)Å
α=90° β=90.907(4)° γ=90°
4-(3-Chloro-2,2-dimethylpropanamido)benzenesulfonamide
C11H15ClN2O3S
Acta Crystallographica Section E (2012) 68, 12 o3430
a=20.4359(11)Å b=7.2437(4)Å c=9.4693(5)Å
α=90° β=98.222(3)° γ=90°
4-(5-Chloropentanamido)benzenesulfonamide
C11H15ClN2O3S
Acta Crystallographica Section E (2012) 68, 12 o3475-o3476
a=8.48720(10)Å b=8.7730(2)Å c=10.4572(3)Å
α=73.711(4)° β=85.281(4)° γ=63.393(3)°
4-[3-(4-Methylpiperidin-1-yl)propanamido]benzenesulfonamide monohydrate
C15H23N3O3S,H2O
Acta Crystallographica Section E (2012) 68, 12 o3481
a=11.3200(3)Å b=7.4068(3)Å c=20.7937(8)Å
α=90° β=96.787(2)° γ=90°